Medicina
Departamento
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadoras/es de University of Texas Southwestern Medical Center (5)
2023
-
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414
-
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
The Lancet Rheumatology
2019
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963
-
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2017
-
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study
Annals of the Rheumatic Diseases, Vol. 76, Núm. 10, pp. 1679-1687